• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks

Study Finds Red Wine Stops Lung Cancer Cells

Vivien Diniz
Mar. 05, 2014 11:44AM PST
Life Science Investing

A recent study by Brock and McMaster University scientists shows that red wine, consumed in moderation, inhibits the spread of lung cancer cells.

A recent study by Brock and McMaster University scientists shows that red wine, consumed in moderation, inhibits the spread of lung cancer cells. However, it’s far too early for physicians to start prescribing Pinot Noir to patients.

According to an article by The Star:

[…]the findings just published in the scientific journal Cancer Cell International did have a positive bouquet. Thestudy found that moderate amounts of red wine inhibit the spread of lung cancer cells.

The study concludes:

Our data suggest that wine may have considerable anti-tumour and chemoprevention properties in lung cancer and deserves further systematic investigation in animal models of lung cancer.

Click here to view the full report.

 

 

life-science-investing
The Conversation (0)

Go Deeper

AI Powered
Life Science Outlook: World Edition

Life Science Outlook: World Edition

MediciNova Announces Collaboration with the University of Sydney Concord Cancer Centre

Latest News

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Lobe Sciences Reports First Quarter 2026 Results and Highlights

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Life Science Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES